Calamos Advisors’s Apyx Medical APYX Stock Holding History

Calamos Advisors’s Portfolio APYX Stock Details APYX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-138,699	Closed	-$1.78M	–	1159
2021 Q4	$1.78M	Sell	138,699 -3,876	-3%	-$54.2K	0.01%	919
2021 Q3	$1.97M	Buy	142,575 +14,794	+12%	+$156K	0.01%	783
2021 Q2	$1.32M	Buy	127,781 +18,409	+17%	+$182K	0.01%	775
2021 Q1	$1.06M	Buy	109,372 +35,056	+47%	+$351K	0.01%	762
2020 Q4	$535K	Buy	+74,316	New	+$493K	﹤0.01%	711
2020 Q1	–	Sell	-137,671	Closed	-$1.16M	–	707
2019 Q4	$1.16M	Buy	+137,671	New	+$995K	0.01%	657

Other funds holding APYX

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

ACM

Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PVI

Pura Vida Investments New York $37M AUM 63.54% 1-Year Est. Return

HKAM

Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Calamos Advisors's APYX Position: Q1 2022 in Review

Calamos Advisors sold out of Apyx Medical (APYX) in Q1 2022, closing a stake of 138,699 shares — an estimated $1.78M sold.

Calamos Advisors first reported a position in APYX in Q4 2019 and held it in 6 quarters. The position peaked at $1.97M in Q3 2021. 71 funds tracked by Wall St. Rank hold APYX as of Q1 2022.

Calamos Advisors reported no remaining Apyx Medical position as of Q1 2022 after selling out during the quarter.
Calamos Advisors sold 138,699 Apyx Medical shares in Q1 2022, an estimated $1.78M.
Calamos Advisors first reported a position in Apyx Medical in Q4 2019 and held it in 6 quarters.
Calamos Advisors's Apyx Medical position peaked at $1.97M in Q3 2021.
71 funds tracked by Wall St. Rank held Apyx Medical as of Q1 2022.

Based on Calamos Advisors's 13F filing for Q1 2022, filed 3 May 2022.